Literature DB >> 21554503

Phages of Pseudomonas aeruginosa: response to environmental factors and in vitro ability to inhibit bacterial growth and biofilm formation.

P Knezevic1, D Obreht, S Curcin, M Petrusic, V Aleksic, R Kostanjsek, O Petrovic.   

Abstract

AIMS: To examine effects of various environmental factors on adsorption and inactivation of Pseudomonas aeruginosa-specific phages: δ (family Podoviridae), J-1, σ-1 and 001A (family Siphoviridae) and their ability to inhibit bacterial growth and biofilm formation. METHODS AND
RESULTS: The phages examined in the study were clonally different, as revealed by RFLP. The temperature in the range 7-44°C had no influence on the adsorption of Podoviridae, but did affect Siphoviridae adsorption, particularly 001A. All phages were significantly stable at pH 5-9, and phages δ and 001A even at pH 3. Most of the examined carbohydrates and exopolysaccharides of the original host efficiently inactivated phage δ, while phages σ-1 and J-1 were inactivated considerably only by the amino acid alanine. Silver nitrate efficiently inactivated all the phages, while Siphoviridae were more resistant to povidone-iodine. Serum of nonimmunized rats had no influence on phage inactivation and adsorption. Only phage δ showed ability to effectively inhibit in vitro bacterial growth and biofilm formation.
CONCLUSIONS: The examined environmental parameters can significantly influence the adsorption and viability of Ps. aeruginosa-specific phages. The phage δ is a good candidate for biocontrol of Ps. aeruginosa. SIGNIFICANCE AND IMPACT OF THE STUDY: The study provides important data on Ps. aeruginosa-specific phage adsorption, inactivation and in vitro lytic efficacy.
© 2011 The Authors. Journal of Applied Microbiology © 2011 The Society for Applied Microbiology.

Entities:  

Mesh:

Year:  2011        PMID: 21554503     DOI: 10.1111/j.1365-2672.2011.05043.x

Source DB:  PubMed          Journal:  J Appl Microbiol        ISSN: 1364-5072            Impact factor:   3.772


  13 in total

1.  Phage-encoded colanic acid-degrading enzyme permits lytic phage infection of a capsule-forming resistant mutant Escherichia coli strain.

Authors:  Min Soo Kim; Young Deuk Kim; Sung Sik Hong; Kwangseo Park; Kwan Soo Ko; Heejoon Myung
Journal:  Appl Environ Microbiol       Date:  2014-11-21       Impact factor: 4.792

Review 2.  Current knowledge in the use of bacteriophages to combat infections caused by Pseudomonas aeruginosa in cystic fibrosis.

Authors:  María José Martínez-Gallardo; Claudia Villicaña; Martha Yocupicio-Monroy; Sofía Lizeth Alcaraz-Estrada; Josefina León-Félix
Journal:  Folia Microbiol (Praha)       Date:  2022-08-05       Impact factor: 2.629

Review 3.  Ecology of Anti-Biofilm Agents II: Bacteriophage Exploitation and Biocontrol of Biofilm Bacteria.

Authors:  Stephen T Abedon
Journal:  Pharmaceuticals (Basel)       Date:  2015-09-09

4.  Pseudomonas putida and Pseudomonas fluorescens Species Group Recovery from Human Homes Varies Seasonally and by Environment.

Authors:  Susanna K Remold; Megan E Purdy-Gibson; Michael T France; Thomas C Hundley
Journal:  PLoS One       Date:  2015-05-29       Impact factor: 3.240

5.  Monitoring in Real Time the Formation and Removal of Biofilms from Clinical Related Pathogens Using an Impedance-Based Technology.

Authors:  Diana Gutiérrez; Claudio Hidalgo-Cantabrana; Ana Rodríguez; Pilar García; Patricia Ruas-Madiedo
Journal:  PLoS One       Date:  2016-10-03       Impact factor: 3.240

6.  Activity of Bacteriophages in Removing Biofilms of Pseudomonas aeruginosa Isolates from Chronic Rhinosinusitis Patients.

Authors:  Stephanie A Fong; Amanda Drilling; Sandra Morales; Marjolein E Cornet; Bradford A Woodworth; Wytske J Fokkens; Alkis J Psaltis; Sarah Vreugde; Peter-John Wormald
Journal:  Front Cell Infect Microbiol       Date:  2017-09-22       Impact factor: 5.293

7.  Microencapsulation of Clostridium difficile specific bacteriophages using microfluidic glass capillary devices for colon delivery using pH triggered release.

Authors:  Gurinder K Vinner; Goran T Vladisavljević; Martha R J Clokie; Danish J Malik
Journal:  PLoS One       Date:  2017-10-12       Impact factor: 3.240

8.  Microencapsulation of Enteric Bacteriophages in a pH-Responsive Solid Oral Dosage Formulation Using a Scalable Membrane Emulsification Process.

Authors:  Gurinder K Vinner; Kerry Richards; Miika Leppanen; Antonia P Sagona; Danish J Malik
Journal:  Pharmaceutics       Date:  2019-09-14       Impact factor: 6.321

Review 9.  Bacteriophage therapy against Pseudomonas aeruginosa biofilms: a review.

Authors:  Zahra Chegini; Amin Khoshbayan; Majid Taati Moghadam; Iman Farahani; Parham Jazireian; Aref Shariati
Journal:  Ann Clin Microbiol Antimicrob       Date:  2020-09-30       Impact factor: 3.944

10.  Are Bordetella bronchiseptica Siphoviruses (Genus Vojvodinavirus) Appropriate for Phage Therapy-Bacterial Allies or Foes?

Authors:  Aleksandra Petrovic Fabijan; Verica Aleksic Sabo; Damir Gavric; Zsolt Doffkay; Gábor Rakhely; Petar Knezevic
Journal:  Viruses       Date:  2021-08-31       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.